Home 2023

Antimalarials

Antimalarial Drug Reverses Bone Loss in Mouse Model of Ostoporosis
Featured

Antimalarial Drug Reverses Bone Loss in Mouse Model of Ostoporosis

Sophia Ktori -
0
Malaria Infection May Be Prevented by Novel Molecule
Infectious Diseases

Malaria Infection May Be Prevented by Novel Molecule

Christina Jackson -
1
Fighting Malaria Based on the Targeting of Biological Clocks
Infectious Diseases

Fighting Malaria Based on the Targeting of Biological Clocks

John Sterling -
13
Exploring Ways to Block Malaria Transmission
Infectious Diseases

Exploring Ways to Block Malaria Transmission

Christina Jackson -
1
Single Dose of Monoclonal Antibody Prevents Malaria Infection in Phase II Study
Drug Discovery

Single Dose of Monoclonal Antibody Prevents Malaria Infection in Phase II Study

Sophia Ktori -
0
Antimalarial Tree Bark Compound Kills Multidrug-Resistant Bacteria in the Lab
Drug Discovery

Antimalarial Tree Bark Compound Kills Multidrug-Resistant Bacteria in the Lab

Sophia Ktori -
0
New Molecular Editing Method Expands Drug Design Possibilities
Drug Discovery

New Molecular Editing Method Expands Drug Design Possibilities

Maria Smit, PhD -
0
Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance
Cancer

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance

Sophia Ktori -
0
Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising COVID-19 Treatment
Coronavirus

Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising COVID-19 Treatment

Julianna LeMieux, PhD -
0
Gilead’s Remdesivir Flunks WHO Trial, Gains “Prequalified” Status
Coronavirus

Gilead’s Remdesivir Flunks WHO Trial, Gains “Prequalified” Status

Alex Philippidis -
0
123...6Page 1 of 6
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.